Back to HomeBeta

ICD-10 Coding for Tardive Dyskinesia(G24.01, G24.09)

Complete ICD-10-CM coding and documentation guide for Tardive Dyskinesia. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

TDNeuroleptic-induced tardive dyskinesia

Related ICD-10 Code Ranges

Complete code families applicable to Tardive Dyskinesia

G24.0-G24.9Primary Range

Other dystonia

This range includes codes for various forms of dystonia, including drug-induced tardive dyskinesia.

Poisoning by, adverse effect of and underdosing of psychotropic drugs, not elsewhere classified

This range includes codes for adverse effects of drugs that may cause tardive dyskinesia.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
G24.01Drug-induced subacute dyskinesiaUse for tardive dyskinesia caused by neuroleptic drugs.
  • Documentation of drug exposure for at least 3 months
  • AIMS score indicating dyskinesia
  • Persistence of symptoms beyond 4 weeks after drug adjustment
G24.09Other drug-induced dyskinesiaUse for atypical presentations of drug-induced dyskinesia.
  • Documentation of atypical dyskinesia presentation
  • Specific drug exposure history

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for tardive dyskinesia

Essential facts and insights about Tardive Dyskinesia

The ICD-10 code for tardive dyskinesia is G24.01, used for drug-induced subacute dyskinesia.

Primary ICD-10-CM Codes for tardive dyskinesia

Drug-induced subacute dyskinesia
Billable Code

Decision Criteria

clinical Criteria

  • Presence of involuntary movements after prolonged neuroleptic use

documentation Criteria

  • Detailed drug history and AIMS score

Applicable To

  • Tardive dyskinesia

Excludes

  • Parkinson's disease (G20)
  • Other dyskinesias (G25.7)

Clinical Validation Requirements

  • Documentation of drug exposure for at least 3 months
  • AIMS score indicating dyskinesia
  • Persistence of symptoms beyond 4 weeks after drug adjustment

Code-Specific Risks

  • Confusion with other movement disorders
  • Omission of drug exposure duration

Coding Notes

  • Ensure documentation specifies the drug and duration of exposure.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Adverse effect of butyrophenones

T43.4X5A
Use to specify the drug causing tardive dyskinesia.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Drug-induced dyskinesia

G25.71
Use for dyskinesia caused by drugs other than neuroleptics.

Drug-induced subacute dyskinesia

G24.01
Use for typical tardive dyskinesia presentations.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Tardive Dyskinesia to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code G24.01.

Impact

Clinical: Misdiagnosis of movement disorder, Regulatory: Non-compliance with coding standards, Financial: Potential claim denials

Mitigation Strategy

Always document drug history and duration, Use templates to ensure completeness

Impact

Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient care.

Mitigation Strategy

Ensure documentation specifies drug-induced cause and duration of exposure.

Impact

Failure to document drug exposure duration can lead to audit issues.

Mitigation Strategy

Use standardized templates and checklists to ensure complete documentation.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Tardive Dyskinesia, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Tardive Dyskinesia

Use these documentation templates to ensure complete and accurate documentation for Tardive Dyskinesia. These templates include all required elements for proper coding and billing.

Patient with tardive dyskinesia due to long-term antipsychotic use

Specialty: Neurology

Required Elements

  • Subjective: Patient's description of movements
  • Objective: AIMS score and movement description
  • Assessment: Diagnosis with ICD-10 code
  • Plan: Treatment adjustments

Example Documentation

**Subjective:** "My jaw keeps moving on its own since starting metoclopramide 3 months ago." **Objective:** - AIMS: 2 (tongue), 2 (lips), 1 (upper extremities) - No Parkinsonian rigidity/tremor **Assessment:** G24.01 - Tardive dyskinesia secondary to metoclopramide (T43.8X5A) **Plan:** 1. Discontinue metoclopramide 2. Valbenazine 40mg daily

Examples: Poor vs. Good Documentation

Poor Documentation Example
Dyskinesia noted.
Good Documentation Example
Chronic oro-mandibular dyskinesia (AIMS 6) with 9-month history of olanzapine 10mg daily for PTSD. No improvement after 6-week drug holiday.
Explanation
The good example provides specific drug history, duration, and AIMS score, which are essential for accurate coding.

Need help with ICD-10 coding for Tardive Dyskinesia? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more